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Behavioral variant frontotemporal dementia (bvFTD) has only recently been associated
with significant striatal atrophy, whereas the striatum appears to be relatively preserved
in Alzheimer’s disease (AD). Considering the critical role the striatum has in cognition
and behavior, striatal degeneration, together with frontal atrophy, could be responsible
of some characteristic symptoms in bvFTD and emerges therefore as promising novel
diagnostic biomarker to distinguish bvFTD and AD. Previous studies have, however, only
taken either cortical or striatal atrophy into account when comparing the two diseases. In
this study, we establish for the first time a profile of fronto-striatal atrophy in 23 bvFTD and
29 AD patients at presentation, based on the structural connectivity of striatal and cortical
regions. Patients are compared to 50 healthy controls by using a novel probabilistic
connectivity atlas, which defines striatal regions by their cortical white-matter connectivity,
allowing us to explore the degeneration of the frontal and striatal regions that are
functionally linked. Comparisons with controls revealed that bvFTD showed substantial
fronto-striatal atrophy affecting the ventral as well as anterior and posterior dorso-lateral
prefrontal cortices and the related striatal subregions. In contrast, AD showed few fronto-
striatal atrophy, despite having significant posterior dorso-lateral prefrontal degeneration.
Direct comparison between bvFTD and AD revealed significantly more atrophy in the
ventral striatal–ventromedial prefrontal cortex regions in bvFTD. Consequently, deficits in
ventral fronto-striatal regions emerge as promising novel and efficient diagnosis biomarker
for bvFTD. Future investigations into the contributions of these fronto-striatal loops on
bvFTD symptomology are needed to develop simple diagnostic and disease tracking
algorithms.
Keywords: frontotemporal dementia, Alzheimer’s disease, striatum, fronto-striatal circuits, ventromedial prefrontal
cortex
Introduction
Behavioral variant frontotemporal dementia (bvFTD) is the most common subtype of frontotem-
poral dementia (FTD), and characterized by deterioration of behavior and cognition, including
impaired social interactions, disinhibition, apathy, or impairment in adaptive functioning, in
association with prominent frontal and temporal lobar atrophy (1).
Imaging studies have described extensively the cortical atrophy that occurs in bvFTD, such as
the characteristic progressive atrophy in frontal and polar temporal lobe brain regions (2, 3). In
Frontiers in Neurology | www.frontiersin.org July 2015 | Volume 6 | Article 1471
Bertoux et al. Fronto-striatal atrophy in bvFTD and AD
particular, atrophy in the ventromedial prefrontal cortex
(VMPFC) has been shown to be specific to bvFTD, as it is already
affected in the early disease stages (4, 5). Nevertheless, prefrontal,
including VMPFC, atrophy is also apparent in many Alzheimer’s
disease (AD) patients (6–8) and thus a sole reliance on VMPFC
atrophy might lack diagnostic specificity to distinguish bvFTD
and AD (7).
Recent anatomical and neuropathological studies have
shown that subcortical regions are also affected in FTD. Among
these subcortical structures, there is mounting evidence that
the striatum is affected particularly early and significantly (4,
9–11). Most consistently, bvFTD show significant cell loss across
the entire striatum (i.e., nucleus accumbens, caudate nucleus,
and putamen) relative to controls and AD (12–14). In contrast,
AD striatal atrophy studies have reported either no change or
only subtle atrophy in the caudate, which has been taken to
be proportional to the whole-brain atrophy that occurs with
disease progression (12, 13, 15). Surprisingly, however, striatal
atrophy has not been considered as a diagnostic biomarker for
bvFTD so far, even though it shows a high-disease sensitivity and
specificity (16, 17).
The striatum has been recognized to act as a critical nexus
in the brain as it receives afferents and efferents from multiple
cortical and subcortical regions and is part of affective/limbic,
cognitive, and motor brain circuits (18, 19). Recent functional
neuroimaging evidence in controls suggests that the functionality
of the striatum does not map onto the discrete anatomical regions
(nucleus accumbens, caudate nucleus, and putamen), instead the
cortico-striatal connectivity is more promising in mapping cog-
nitive functions to striatal regions comprising multiple anatomi-
cal subregions. Indeed, reward-related cognition, such as reward
valuation or anticipation, has been associated with both ventral
striatal and VMPFC activations in fMRI studies (20). Similarly,
dorsal striatal and motor cortex activation has been associated
with motor planning and execution processes (21, 22). Thus,
mapping the cortico-striatal and particularly fronto-striatal atro-
phy based on their connectivity instead of anatomical boundaries
emerges as important in understanding the diagnostic utility of
striatal atrophy in bvFTD and AD. Indeed, combined atrophy of
striatal and frontal regions might provide better neuroimaging
biomarkers for bvFTD pathology than each region in isolation.
The aim of the current study is to establish a profile of fronto-
striatal atrophy in bvFTD and AD at clinical presentation. Instead
of exploring the structural connectivity between the frontal cortex
and the striatum, or using anatomically defined discrete striatal
regions (nucleus accumbens, caudate nucleus, and putamen), as
previous studies have done, we employed a novel probabilistic
connectivity striatal atlas [Oxford-GSK-Imanova Striatal Connec-
tity Atlas (23)], which defines striatal regions by their cortical
white-matter connectivity. Thus, the atlas enables identification
of cortical and substriatal regions that are structurally linked and
have therefore likely shared functions. Using this novel approach
based on both functionality and anatomy, we hypothesized that
bvFTD and AD would show distinct patterns of fronto-striatal
atrophy, with bvFTD showing more VMPFC and ventral striatal
atrophy while AD would should few striatal atrophy despite hav-
ing PFC atrophy.
Materials and Methods
Case Selection
Patients were selected from the Frontotemporal Dementia
ResearchGroup (FRONTIER) atNeuroscienceResearchAustralia
(NeuRA) following study approval by theUniversity of New South
Wales Human research Ethics Advisory Panel D (Biomedical,
ref. 100035). Every participant signed an informed consent and
the study was in compliance with the Declaration of Helsinki. It
resulted in a sample of 23 bvFTD, 29 AD patients, and 50 controls.
All bvFTD patients met current consensus diagnosis criteria (24).
In light of the recent recognition of the phenocopy syndrome (25)
only bvFTD patients with evidence of clear decline as reported by
the caregivers and atrophy on MRI scans were included in the
study. All AD patients met NINCNS-ADRDA diagnostic crite-
ria (26) for probable AD (see Table 1 for demographic details).
Healthy controls were selected from a healthy volunteer panel or
were spouses/carers of patients.
Clinical Assessment
All patients underwent the frontotemporal dementia rating scale
[FRS (27)], a clinical scale based on carers’ interview aiming to
assess disease severity; the Cambridge behavioral inventory [CBI
(28)] to evaluates behavioral symptoms and the Addenbrooke’s
cognitive examination revised [ACE-R (29)] as a measure of
cognitive efficiency.
Imaging Acquisition
All patient and controls underwent the same imaging proto-
col with whole-brain T1 using a 3-T Philips MRI scanner with
standard quadrature head coil (eight channels). The 3D T1-
weighted sequences were acquired as follows: coronal orientation,
256 256 matrix, 200 slices, 1mm 1mm in-plane resolution,
slice thickness 1mm, TE/TR= 2.6/5.8ms.
Voxel Based Morphometry Analysis:
Pre-Processing
3D T1-weighted sequences were analyzed with FSL-voxel based
morphometry (VBM), a VBM analysis (30, 31), which is part of
the FSL software package (http://www.fmrib.ox.ac.uk/fsl/fslvbm/
index.html) (32). First, tissue segmentation was carried out
TABLE 1 | Demographics, behavioral, and neuropsychological screening
data for bvFTD, AD, and controls.
Demographics, behavioral
and cognitive tests
bvFTD AD Controls
N 23 29 50
Sex (M/F) 15/8 18/11 22/28
Mean age (years) 60:9 (9:8)* 65:0 (8:1) 68:8 (6:3)
Duration of disease (years) 3:7 (2:4)† 2:8 (1:0)† N.A.
FRS  1:3 (1:6)† 0:8 (1:5)† N.A.
CBI (total score) 72:5 (33:7)†,* 38:1 (22:9)†,* 7:1 (8:1)
ACE-R (total score) 73:6 (15:8)* 77:1 (9:7)* 94:6 (3:6)
*p<0.001 compared to controls.
†p<0.001 when comparing patients groups.
Mean (SD).
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using FMRIB’s automatic segmentation tool (FAST) (33) from
brain-extracted images. The resulting gray-matter partial vol-
ume maps were then aligned to the Montreal Neurological Insti-
tute standard space (MNI152) using the non-linear registration
approach using FNIRT (34, 35), which uses a b-spline repre-
sentation of the registration warp field (36). Default settings
were used for these steps, but quality control for each scan
was performed and slight alteration of the search space for the
segmentation algorithm was performed for some patients with
severe atrophy. The registered partial volume maps were then
modulated (to correct for local expansion or contraction) by
dividing them by the Jacobian of the warp field. Importantly, the
Jacobian modulation step did not include the affine part of the
registration, which means that the data are normalized for head
size as a scaling effect (37). The modulated images were then
smoothed with an isotropic Gaussian kernel with a SD of 2mm
(FWHM: 5mm).
Voxel Based Morphometry Analysis: ROI
Analyses
Instead of using arbitrary anatomical landmarks to subdivide the
striatum, we use substriatal ROI from the Oxford-GSK-Imanova
Striatal Connectity Atlas (23), a probabilistic atlas of substriatal
regions segmented according to their white-matter connectiv-
ity to cortical regions. We selected three striatal ROIs, designed
according to their prefrontal connexions, each being associated
with a particular anatomical region within the frontal lobe: the
ventromedial PFC (VMPFC), the anterior dorso-lateral PFC (A-
DLPFC), and posterior dorso-lateral PFC (P-DLPFC). As a com-
plement of this analysis, we also investigated the atrophy in each
related prefrontal ROIs.
Striatum VMPFC-Connected ROI
This striatal subregion was defined according to the projections
from the VMPFC (include the projections from anterior, medial,
and posterior orbital gyri, from the gyrus rectus and from the
subcallosal gyrus – together composing the VMPFC ROI).
Striatum A-DLPFC-Connected and A-DLPFC ROI
This striatal region was defined according to the projections from
the anterior DLPFC (which include the projections of the rostral
superior and middle frontal gyri and from the dorsal prefrontal
cortex – together composing the A-DLPFC ROI).
Striatum P-DLPFC-Connected and P-DLPFC ROI
This ROI was defined according to the projections from the
more posterior dorso-lateral regions of the frontal lobe, with-
out the precentral gyrus (including the caudal portions of lat-
eral and medial superior gyrus as well as the caudal mid-
dle and caudal inferior frontal gyri – together composing the
P-DLPFC).
The three groups were contrasted (1) for each striatal ROI
(striatal analysis) and (2) for each prefrontal ROI (prefrontal
analysis). A voxelwise general linear model (GLM) was applied
and permutation-based non-parametric testing was used to form
clusters with the threshold-free cluster enhancement (TFCE)
method (35), tested for significance at p< 0.05, corrected for
multiple comparisons via family-wise error (FWE) correction
across space. Age and disease severity asmeasured by the FRS (27)
was included as covariates in all analyses. Sex was not included
as a covariate because it did have no effect on the variables of
interest.
Finally, in patient groups, the mean values of gray-matter
intensity were extracted from the result maps given by the
contrast with the control group. The extraction of these val-
ues was performed for each ROI, for the results of both
striatal (striatum-VMPFC connected, striatum-A-DLPFC con-
nected, striatum-P-DLPFC connected) and cortical analyses
(VMPFC, A-DLPFC, P-DLPFC). Striatal and prefrontal mean
gray-matter intensity values were then correlated to investigate
the relationship of striatal and prefrontal atrophy within bvFTD
and AD.
Statistics
Using SPSS 20 (SPSS, Chicago, IL, USA), one-way ANOVA were
conducted to compare demographic and background neuropsy-
chological data cross groups, followed by Tukey post hoc tests.
Variables were plotted and checked for normality of distribution
by Kolmogorov–Smirnov tests. Variables revealing non-normal
distributions were log transformed and the appropriate log val-
ues were used in the analyses. Correlations were explored with
Pearson coefficient and were corrected for multiple comparison
(Bonferroni’s correction).
Results
Demographics, Behavioral, and Cognitive
Screening Measures
Participants did not differ significantly on education or gen-
der distribution; however, controls were significantly older than
bvFTD (p< 0.001) but not AD (p> 0.1) (Table 1). bvFTDpatients
had also a higher disease severity as measured by the FRS com-
pared to AD (p< 0.001).
On the behavioral screening test (CBI), bvFTD patients per-
formed worse than AD and both patient groups were impaired
compared to controls (all p values <0.001). On general cogni-
tive screening, controls performed significantly better than both
patient groups (p< 0.001), whereas bvFTD and AD did not differ
significantly from each other.
VBM – Group Analyses
Striatum Analysis
Striatum VMPFC-connected ROI
Compared to controls, bvFTD patients showed widespread
striatal atrophy, including bilateral nucleus accumbens, cau-
date nucleus, and putamen (Figure 1). Compared to con-
trols, Alzheimer patients (Figure 2) showed a striatal atro-
phy that encompassed bilateral caudate nucleus and putamen.
When contrasting directly bvFTD with AD patients, analysis
revealed striatal atrophy in the right anterior caudate nucleus
(Figure 3).
Striatum A-DLPFC-connected ROI
Compared to controls, bvFTD patients presented with a stri-
atal atrophy that included bilateral nuclei accumbens, caudate
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FIGURE 1 | Voxel-based morphometry analyses showing areas that were
atrophic in bvFTD compared to controls for the three ROIs (VMPFC,
A-DLPFC, and P-DLPFC), in striatum (left) and cortex (right). Clusters are
overlaid on the MNI standard brain. Colored voxels show regions that were
significant in the analyses for p<0.05 corrected for multiple comparisons via
family-wise error (FWE) and a voxel threshold of 20 contiguous voxels. Images
follow radiological convention (left is right and right is left) and “L” indicates the
left for coronal slices.
FIGURE 2 | Voxel-based morphometry analyses showing areas that were
atrophic in AD compared to controls for three ROIs (VMPFC, A-DLPFC,
and P-DLPFC), in striatum (left) and cortex (right). Clusters are overlaid on
the MNI standard brain. Colored voxels show regions that were significant in the
analyses for p<0.05 corrected for multiple comparisons via family-wise error
(FWE) and a voxel threshold of 20 contiguous voxels. Images follow radiological
convention (left is right and right is left) and “L” indicates the left for coronal
slices.
nuclei, pre-commissural putamen, and, to a lesser degree,
post-commissural putamen. Compared to controls, AD showed
an atrophy of the striatum characterized by bilateral atrophy of the
caudate nucleus but prominent in the left side where it extended
to the pre-commissural putamen. No differences were observed
when contrasting bvFTD and AD directly.
Striatum P-DLPFC-connected ROI
Contrasted to controls, bvFTD presented with a striatal atro-
phy that involved bilateral caudate nuclei as well as right puta-
men, where degeneration was prominent in its pre-commissural
part. Compared to controls, Alzheimer patients showed less pro-
nounced striatal atrophy than bvFTD, which was circumscribed
to the left caudate nucleus. No significant voxels were found when
contrasting bvFTD with AD directly.
Prefrontal Analysis
VMPFC ROI
Contrasted to controls, bvFTD showed a bilateral and widespread
atrophy of the ventral part of the frontal cortex, including lateral
orbito-frontal cortex andmedian areas from the subcallosal gyrus
to the median frontal pole. AD patients showed a bilateral atro-
phy of the ventro-median and lateral prefrontal cortices. When
contrasting bvFTD with AD, bvFTD showed a greater VMPFC
atrophy, circumscribed to the bilateral ventral median frontal cor-
tex and subcallosal/paracingulate cortices, with rostral areas being
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FIGURE 3 | Voxel-based morphometry analyses showing areas that
were atrophic in bvFTD compared to AD. Results were only found in
VMPFC and A-DLPFC ROIs. Clusters are overlaid on the MNI standard
brain. Colored voxels show regions that were significant in the analyses for
p<0.05 corrected for multiple comparisons via Family-wise Error (FWE)
and a voxel threshold of 20 contiguous voxels. Images follow radiological
convention (left is right and right is left) and “L” indicates the left for coronal
slices.
FIGURE 4 | Plots of the correlation between the mean individual
grey-matter intensity values extracted from the striatum-
VMPFC-connected and the striatum-A-DLPFC-connected and in the
VMPFC and A-DLPFC in bvFTD patients (left frame) and from the
striatum-P-DLPFC-connected and P-DLPFC in AD patients (right
frame).
relatively spared, but extended laterally to the inferior frontal
gyrus.
A-DLPFC ROI
Compared to controls, bvFTD patients presented with a wide and
bilateral cortical atrophy within the median and lateral prefrontal
areas that included the paracingulate gyrus and themedian part of
the superior frontal gyrus, the middle frontal gyrus and the dorsal
frontal pole. AD also presented with cortical atrophy that involved
the same regions that in bvFTD, but to a lesser degree. When
contrasting bvFTD to AD, atrophy was found in the bilateral
superior gyrus, the frontal pole, and in the paracingulate gyrus,
with a strong predominance in the right lobe.
P-DLPFC ROI
Contrasted to controls, the dlPFC in bvFTD was characterized
by a bilateral atrophy of the precentral gyrus, extended to the
caudal portions of the superior frontal gyrus and the opercular
cortex as well as to the supplementary motor cortex. In AD, the
same pattern of cortical atrophy was observed, but again to a
lesser degree than bvFTD. No significant voxels were found when
contrasting bvFTD with AD directly.
Relationship Between Striatal and Prefrontal
Atrophy
In the bvFTD group, the atrophy of the striatal subregions con-
nected to the VMPFC was highly related (R= 0.81; p< 10 6) to
the atrophy of the VMPFC (Figure 4). A significant correlation
was also observed for the A-DLPFC (0.63; p< 0.001) and its
connected striatal subregions, but not for the P-DLPFC (R= 0.31,
NS). In the AD group, the atrophy in the VMPFC and in its
connected striatal regionwas not correlated (R= 0.23, NS), as well
as in the A-DLPFC and in its striatal subregions (R= 0.32, NS). In
contrast, the atrophy in the P-DLPFC and in its striatal-connected
region was significantly correlated (R= 0.66; p< 10 4).
Discussion
Using a novel probabilistic connectivity atlas, we demonstrated
different patterns of fronto-striatal atrophy in bvFTD and AD
based on the structural connectivity of prefrontal and striatal
regions (Table 2). More specifically, bvFTD patients showed
significant striatal and global prefrontal atrophy, whereas AD
patients showed only minor striatal atrophy while having sig-
nificant dorso-lateral prefrontal atrophy. In particular, striatal
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TABLE 2 | Schematic notation of the results in the striatal or frontal regions for the three different imaging contrasts.
Striatal regions connected to Frontal regions
VMPFC A-DLPFC P-DLPFC VMPFC A-DLPFC P-DLPFC
bvFTD vs. controls ++ +++ ++ ++++ ++++ ++++
AD vs. controls + ++ + +++ +++ +++
bvFTD vs. AD + +++ +++
+ Indicates the presence of atrophy.
+>100 voxels; +++>500 voxels; ++++>1000 voxels; ++++> 5000 voxels.
regions connecting VMPFC cortex areas, including the ventral
striatum were severely affected in bvFTD compared to AD. More
importantly, we found clear correlations between striatal and cor-
tical regions, which dissociated for bvFTD and AD, with bvFTD
showing only atrophy correlations between VMPFC and related
striatal regions as well as between anterior DLPFC and con-
nected striatal regions, while AD showing only atrophy correla-
tions between posterior DLPFC and related striatal regions. This
suggests for the first time that only some of the striatal atrophy
in bvFTD and AD is related to specific cortical atrophy in both
diseases.
Inmore detail, we replicated the well-known prefrontal atrophy
in bvFTD, affecting ventral, rostral, and dorsal regions within
the PFC (2, 3). We observed a prefrontal atrophy in AD as well,
affecting every region within the PFC but to a lesser degree com-
pared to bvFTD, and especially in the VMPFC.We also replicated
(Figure 1) previous striatal degeneration results in bvFTD with
significant widespread striatal atrophy evident at presentation (4,
9, 10, 12, 13). Similarly, we also found a subtle atrophy (Figure 2)
in the striatum for AD, in particular, in the caudate nucleus and
putamen, thus replicating previous studies (7, 38, 39).
The striato-prefrontal atrophy found in AD might at first sight
surprising, as AD is commonly characterized by temporal and
parietal atrophy (40) although diffuse atrophywas observed inAD
(41), involving frontal regions as well. One possible explanation of
these results is that the striatal subregions covary with the general
cortical atrophy seen in AD. Striatal atrophy in AD would thus
occur as a consequence of the cortical atrophy (15), i.e., a knock-
on effect with disease duration. Different disease mechanisms
could be then responsible for striatal atrophy in AD and bvFTD.
Indeed, while significant caudate atrophy, together with thalamus,
has been recently reported in familial AD (42), studies in sporadic
AD only reported a subtle caudate volume loss, quantified to be
around 6–7% compared with age-matched control (38), although
a different profile may be observed according to the age-of-onset
and the apolipoprotein E genotype, as recently suggested (43).
In contrast, bvFTD have been reported to show a 25% caudate
volume reduction (44). Differences between sporadic and familial
AD suggest that while the same cortico-subcortical network atro-
phy is involved in both forms of AD, each of the nodes of this cir-
cuit are differentially involved in the two respective degeneration
processes (42).
In contrast, in bvFTD, the atrophy of the striatum could be
concomitant to the cortical atrophy. Indeed, while striatal degen-
eration could be considered as a consequence of the frontal atro-
phy occurring early in the disease course, it is likely that the
crucial importance of the connection between frontal lobes and
striatum has a direct impact on frontal atrophy as well, and this
is supported by the strong correlation found between gray-matter
loss in the VMPFC and the ventral striatum in bvFTD and not
in AD. VMPFC and ventral striatum are richly interconnected
(45) and both areas are involved in the degeneration pattern of
bvFTD. While the striatal atrophy could be a consequence of
VMPFC atrophy, one can hypothesize that VMPFC could, in turn,
be affected by the striatal atrophy. Given the central place, the
striatumhas in fronto-striatal network (18), the trans-striatal atro-
phy in bvFTD could be a resultant of more general fronto-striatal
network dysfunction. Along these lines, Looi and colleagues (16)
hypothesized that a disruption of any component of the fronto-
striatal circuitry could not only affect the functions of this network
but also may have up- and downstream effects attributed to trans-
synaptic neurodegeneration. Nevertheless, this still needs to be
verified longitudinally, and it would be, in particular, important
to contrast fronto-striatal with striatal connections to parietal and
temporal cortical areas to see reveal different patterns of up and
downstream synaptic changes.
Among all the striato-cortical regions investigated, the limbic
network appeared to discriminate most clearly bvFTD and AD
(Figure 3). This region includes ventromedial, subcallosal, and
polar prefrontal cortices as well as the nucleus accumbens, ante-
rior ventral caudate nucleus, and ventral putamen. Dysfunctions
of the VMPFC in bvFTD are well known and the atrophy of this
region is considered as a characteristic of bvFTD (2, 5, 46). Impor-
tantly, atrophy in this region has also been directly associated with
specific symptoms in bvFTD, such as neuropsychiatric changes
(47), loss of insight (48), inhibitory dysfunction (49, 50), and
social cognition impairments (50). This has led to suggestions that
frontal and particularly VMPFC specific changes are potentially
powerful diagnostic markers for FTD pathology, even in bvFTD
patients presenting with additional memory problems (51, 52).
Similarly, atrophy of the ventral striatum has been previously
described in bvFTD but not in AD (12, 13, 39, 41, 53), which
is consistent with our results. Given the importance of the con-
nections between VMPFC and ventral striatum (23, 45) and the
role of this ventral circuit in reward-guided choice behavior (54),
the conjunctive and respective investigations of the VMPFC and
ventral striatum could represent promising ways to enhance the
diagnosis of bvFTD. This dovetails nicely with previous find-
ings, such as the association between disinhibition and fronto-
striatal atrophy in bvFTD (17, 55), as well as other behavioral
features, such as apathy, reduced empathy, and aberrant motor
behavior (56, 57). Finally, some studies have also reported that
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atrophy of the striatum directly predicts executive, language, and
psychomotor dysfunctions and poorer general cognition (10, 13).
Taken together, these results suggest that numerous cognitive or
behavioral measures could be utilized to detect striatal atrophy.
Therefore, more specific delineation of the respective frontal and
striatal contributions to cognition and behavior is needed in order
to develop novel scales or tasks assessing pure striatal dysfunc-
tions, which could be an early biomarker of bvFTD. For example,
impaired probabilistic association learning has been found in
FTD and related to striatal atrophy (58), as well as impulsivity
related to delay discounting (59). These studies are encouraging
but do not specifically delineate or dissociate striatal and cortical
contributions, which should be explored in the future.
On a clinical level, the diagnosis of bvFTD remains challeng-
ing purely on clinical, cognitive, and behavioral biomarkers. The
revised diagnostic criteria of bvFTD (24) now require evidence
of frontal and/or temporal atrophy on imaging, in order to qual-
ify for a diagnosis of probable bvFTD. Nevertheless, as outlined
above, cortical markers of atrophy might be not as helpful in
distinguishing bvFTD and AD, in particular, for dorso-lateral
prefrontal changes, which can be associated with both conditions.
In particular, a percentage of AD patients present with prefrontal
deficits (60), which can make them appear clinically very similar
to bvFTD (61). Although the replication of our findings is needed
in larger group of patients, they indicate that striatal atrophy
in combination with VMPFC atrophy should be much more
promising in distinguishing those patients in vivo. Thus, the pure
clinical and diagnostic focus on cortical changes in bvFTD and
ADmight have overshadowed themore important striatal changes
that are mostly present in bvFTD. Employment of striatal atrophy
measures should have much higher diagnostic specificity than
any cortical atrophy measures when attempting to discriminate
bvFTD and AD, even at presentation (16). Clearly, it would be
very important to confirm this notion in pathologically confirmed
cases of bvFTD and AD. Also, it would be clearly important to
track cortico-striatal changes longitudinally to map the network
atrophy over the disease course for both conditions.
These findings have important clinical and diagnostic implica-
tions for bvFTD as, to date, the substantial striatal degeneration
occurring in the course of the disease is not taken into account.
Previous investigations have only taken into account either corti-
cal or striatal atrophy in bvFTD and AD, while the current study
reveals prefrontal-striatal atrophy profiles across the diseases. This
approach wasmade possible by a novel striato-cortical anatomical
connectivity atlas derived from diffusion magnetic resonance
imaging and probabilistic tractography. This novel method, tak-
ing into account functional links between brain structures in a
VBM – or structural – analysis leads toward network atrophy
profiles and away from region specific diagnostics, which may be
simplistic. Further, structural connectivity data are grounded on
anatomical diffusion data, which are an alternative to functional
resting-state networks data.
Conclusion
In summary, our results show different profiles of cortico-striatal
network atrophy in bvFTD and AD. Notably, the limbic circuitry
network (ventral striatum and median/ventro-median prefrontal
cortex) seems to best distinguish between the groups, with bvFTD
manifesting considerably greater atrophy in these regions. It is
important to investigate whether white-matter tract DTI findings
would give a similar result for the identified networks. Further-
more, despite the numerous and converging studies that have
established the importance of the limbic fronto-striatal circuit in
reward-cognition and behavior (62), to date, the role of the stria-
tum in the generation of bvFTD symptoms is unclear and need
to be addressed by future studies analyzing correlation between
behavioral scales or cognitive testing and striatal subregions.
Such studies should delineate frontal and striatal contributions to
behavior. Taken together, our current findings could have major
implications for future diagnostic guidelines of bvFTD as they will
allow taking into account the striatal changes in FTD that have
been so far overlooked in the diagnostic process and help in the
distinction process between bvFTD and AD.
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